Global Oncology Targeted Therapy Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Targeted therapy is a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.
LPI (LP Information)' newest research report, the “Oncology Targeted Therapy Industry Forecast” looks at past sales and reviews total world Oncology Targeted Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Oncology Targeted Therapy sales for 2023 through 2029. With Oncology Targeted Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology Targeted Therapy industry.
This Insight Report provides a comprehensive analysis of the global Oncology Targeted Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncology Targeted Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncology Targeted Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology Targeted Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology Targeted Therapy.
The global Oncology Targeted Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Oncology Targeted Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Oncology Targeted Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Oncology Targeted Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Oncology Targeted Therapy players cover Bayer, Eisai, Zelgen, Cipla, Natco Pharma, AstraZeneca, Novartis, Roche and Bristol-Myers Squibb, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Targeted Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Targeted therapy is a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.
LPI (LP Information)' newest research report, the “Oncology Targeted Therapy Industry Forecast” looks at past sales and reviews total world Oncology Targeted Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Oncology Targeted Therapy sales for 2023 through 2029. With Oncology Targeted Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncology Targeted Therapy industry.
This Insight Report provides a comprehensive analysis of the global Oncology Targeted Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oncology Targeted Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Oncology Targeted Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncology Targeted Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncology Targeted Therapy.
The global Oncology Targeted Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Oncology Targeted Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Oncology Targeted Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Oncology Targeted Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Oncology Targeted Therapy players cover Bayer, Eisai, Zelgen, Cipla, Natco Pharma, AstraZeneca, Novartis, Roche and Bristol-Myers Squibb, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Targeted Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Sorafenib
- Lenvatinib
- Regorafenib
- Osimertinib
- Anlotinib
- Alectinib
- Other
- Hospital
- Retail Pharmacy
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer
- Eisai
- Zelgen
- Cipla
- Natco Pharma
- AstraZeneca
- Novartis
- Roche
- Bristol-Myers Squibb
- Pfizer
- BEACON Pharma
- Jiangxi Shanxiang
- Yao Pharma
- CSPC
- CHIATAI Tianqing
- Simcere
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology Targeted Therapy Market Size 2018-2029
2.1.2 Oncology Targeted Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Oncology Targeted Therapy Segment by Type
2.2.1 Sorafenib
2.2.2 Lenvatinib
2.2.3 Regorafenib
2.2.4 Osimertinib
2.2.5 Anlotinib
2.2.6 Alectinib
2.2.7 Other
2.3 Oncology Targeted Therapy Market Size by Type
2.3.1 Oncology Targeted Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Oncology Targeted Therapy Market Size Market Share by Type (2018-2023)
2.4 Oncology Targeted Therapy Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 Oncology Targeted Therapy Market Size by Application
2.5.1 Oncology Targeted Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Oncology Targeted Therapy Market Size Market Share by Application (2018-2023)
3 ONCOLOGY TARGETED THERAPY MARKET SIZE BY PLAYER
3.1 Oncology Targeted Therapy Market Size Market Share by Players
3.1.1 Global Oncology Targeted Therapy Revenue by Players (2018-2023)
3.1.2 Global Oncology Targeted Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Oncology Targeted Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLOGY TARGETED THERAPY BY REGIONS
4.1 Oncology Targeted Therapy Market Size by Regions (2018-2023)
4.2 Americas Oncology Targeted Therapy Market Size Growth (2018-2023)
4.3 APAC Oncology Targeted Therapy Market Size Growth (2018-2023)
4.4 Europe Oncology Targeted Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Oncology Targeted Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Oncology Targeted Therapy Market Size by Country (2018-2023)
5.2 Americas Oncology Targeted Therapy Market Size by Type (2018-2023)
5.3 Americas Oncology Targeted Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Targeted Therapy Market Size by Region (2018-2023)
6.2 APAC Oncology Targeted Therapy Market Size by Type (2018-2023)
6.3 APAC Oncology Targeted Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncology Targeted Therapy by Country (2018-2023)
7.2 Europe Oncology Targeted Therapy Market Size by Type (2018-2023)
7.3 Europe Oncology Targeted Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology Targeted Therapy by Region (2018-2023)
8.2 Middle East & Africa Oncology Targeted Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Oncology Targeted Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLOGY TARGETED THERAPY MARKET FORECAST
10.1 Global Oncology Targeted Therapy Forecast by Regions (2024-2029)
10.1.1 Global Oncology Targeted Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Oncology Targeted Therapy Forecast
10.1.3 APAC Oncology Targeted Therapy Forecast
10.1.4 Europe Oncology Targeted Therapy Forecast
10.1.5 Middle East & Africa Oncology Targeted Therapy Forecast
10.2 Americas Oncology Targeted Therapy Forecast by Country (2024-2029)
10.2.1 United States Oncology Targeted Therapy Market Forecast
10.2.2 Canada Oncology Targeted Therapy Market Forecast
10.2.3 Mexico Oncology Targeted Therapy Market Forecast
10.2.4 Brazil Oncology Targeted Therapy Market Forecast
10.3 APAC Oncology Targeted Therapy Forecast by Region (2024-2029)
10.3.1 China Oncology Targeted Therapy Market Forecast
10.3.2 Japan Oncology Targeted Therapy Market Forecast
10.3.3 Korea Oncology Targeted Therapy Market Forecast
10.3.4 Southeast Asia Oncology Targeted Therapy Market Forecast
10.3.5 India Oncology Targeted Therapy Market Forecast
10.3.6 Australia Oncology Targeted Therapy Market Forecast
10.4 Europe Oncology Targeted Therapy Forecast by Country (2024-2029)
10.4.1 Germany Oncology Targeted Therapy Market Forecast
10.4.2 France Oncology Targeted Therapy Market Forecast
10.4.3 UK Oncology Targeted Therapy Market Forecast
10.4.4 Italy Oncology Targeted Therapy Market Forecast
10.4.5 Russia Oncology Targeted Therapy Market Forecast
10.5 Middle East & Africa Oncology Targeted Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Oncology Targeted Therapy Market Forecast
10.5.2 South Africa Oncology Targeted Therapy Market Forecast
10.5.3 Israel Oncology Targeted Therapy Market Forecast
10.5.4 Turkey Oncology Targeted Therapy Market Forecast
10.5.5 GCC Countries Oncology Targeted Therapy Market Forecast
10.6 Global Oncology Targeted Therapy Forecast by Type (2024-2029)
10.7 Global Oncology Targeted Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Oncology Targeted Therapy Product Offered
11.1.3 Bayer Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Eisai
11.2.1 Eisai Company Information
11.2.2 Eisai Oncology Targeted Therapy Product Offered
11.2.3 Eisai Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Eisai Main Business Overview
11.2.5 Eisai Latest Developments
11.3 Zelgen
11.3.1 Zelgen Company Information
11.3.2 Zelgen Oncology Targeted Therapy Product Offered
11.3.3 Zelgen Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Zelgen Main Business Overview
11.3.5 Zelgen Latest Developments
11.4 Cipla
11.4.1 Cipla Company Information
11.4.2 Cipla Oncology Targeted Therapy Product Offered
11.4.3 Cipla Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Cipla Main Business Overview
11.4.5 Cipla Latest Developments
11.5 Natco Pharma
11.5.1 Natco Pharma Company Information
11.5.2 Natco Pharma Oncology Targeted Therapy Product Offered
11.5.3 Natco Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Natco Pharma Main Business Overview
11.5.5 Natco Pharma Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Oncology Targeted Therapy Product Offered
11.6.3 AstraZeneca Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Oncology Targeted Therapy Product Offered
11.7.3 Novartis Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 Roche
11.8.1 Roche Company Information
11.8.2 Roche Oncology Targeted Therapy Product Offered
11.8.3 Roche Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Roche Main Business Overview
11.8.5 Roche Latest Developments
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Information
11.9.2 Bristol-Myers Squibb Oncology Targeted Therapy Product Offered
11.9.3 Bristol-Myers Squibb Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Bristol-Myers Squibb Main Business Overview
11.9.5 Bristol-Myers Squibb Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Oncology Targeted Therapy Product Offered
11.10.3 Pfizer Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 BEACON Pharma
11.11.1 BEACON Pharma Company Information
11.11.2 BEACON Pharma Oncology Targeted Therapy Product Offered
11.11.3 BEACON Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 BEACON Pharma Main Business Overview
11.11.5 BEACON Pharma Latest Developments
11.12 Jiangxi Shanxiang
11.12.1 Jiangxi Shanxiang Company Information
11.12.2 Jiangxi Shanxiang Oncology Targeted Therapy Product Offered
11.12.3 Jiangxi Shanxiang Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Jiangxi Shanxiang Main Business Overview
11.12.5 Jiangxi Shanxiang Latest Developments
11.13 Yao Pharma
11.13.1 Yao Pharma Company Information
11.13.2 Yao Pharma Oncology Targeted Therapy Product Offered
11.13.3 Yao Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Yao Pharma Main Business Overview
11.13.5 Yao Pharma Latest Developments
11.14 CSPC
11.14.1 CSPC Company Information
11.14.2 CSPC Oncology Targeted Therapy Product Offered
11.14.3 CSPC Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 CSPC Main Business Overview
11.14.5 CSPC Latest Developments
11.15 CHIATAI Tianqing
11.15.1 CHIATAI Tianqing Company Information
11.15.2 CHIATAI Tianqing Oncology Targeted Therapy Product Offered
11.15.3 CHIATAI Tianqing Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 CHIATAI Tianqing Main Business Overview
11.15.5 CHIATAI Tianqing Latest Developments
11.16 Simcere
11.16.1 Simcere Company Information
11.16.2 Simcere Oncology Targeted Therapy Product Offered
11.16.3 Simcere Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Simcere Main Business Overview
11.16.5 Simcere Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Oncology Targeted Therapy Market Size 2018-2029
2.1.2 Oncology Targeted Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Oncology Targeted Therapy Segment by Type
2.2.1 Sorafenib
2.2.2 Lenvatinib
2.2.3 Regorafenib
2.2.4 Osimertinib
2.2.5 Anlotinib
2.2.6 Alectinib
2.2.7 Other
2.3 Oncology Targeted Therapy Market Size by Type
2.3.1 Oncology Targeted Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Oncology Targeted Therapy Market Size Market Share by Type (2018-2023)
2.4 Oncology Targeted Therapy Segment by Application
2.4.1 Hospital
2.4.2 Retail Pharmacy
2.4.3 Other
2.5 Oncology Targeted Therapy Market Size by Application
2.5.1 Oncology Targeted Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Oncology Targeted Therapy Market Size Market Share by Application (2018-2023)
3 ONCOLOGY TARGETED THERAPY MARKET SIZE BY PLAYER
3.1 Oncology Targeted Therapy Market Size Market Share by Players
3.1.1 Global Oncology Targeted Therapy Revenue by Players (2018-2023)
3.1.2 Global Oncology Targeted Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Oncology Targeted Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ONCOLOGY TARGETED THERAPY BY REGIONS
4.1 Oncology Targeted Therapy Market Size by Regions (2018-2023)
4.2 Americas Oncology Targeted Therapy Market Size Growth (2018-2023)
4.3 APAC Oncology Targeted Therapy Market Size Growth (2018-2023)
4.4 Europe Oncology Targeted Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Oncology Targeted Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Oncology Targeted Therapy Market Size by Country (2018-2023)
5.2 Americas Oncology Targeted Therapy Market Size by Type (2018-2023)
5.3 Americas Oncology Targeted Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Targeted Therapy Market Size by Region (2018-2023)
6.2 APAC Oncology Targeted Therapy Market Size by Type (2018-2023)
6.3 APAC Oncology Targeted Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Oncology Targeted Therapy by Country (2018-2023)
7.2 Europe Oncology Targeted Therapy Market Size by Type (2018-2023)
7.3 Europe Oncology Targeted Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Oncology Targeted Therapy by Region (2018-2023)
8.2 Middle East & Africa Oncology Targeted Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Oncology Targeted Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ONCOLOGY TARGETED THERAPY MARKET FORECAST
10.1 Global Oncology Targeted Therapy Forecast by Regions (2024-2029)
10.1.1 Global Oncology Targeted Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Oncology Targeted Therapy Forecast
10.1.3 APAC Oncology Targeted Therapy Forecast
10.1.4 Europe Oncology Targeted Therapy Forecast
10.1.5 Middle East & Africa Oncology Targeted Therapy Forecast
10.2 Americas Oncology Targeted Therapy Forecast by Country (2024-2029)
10.2.1 United States Oncology Targeted Therapy Market Forecast
10.2.2 Canada Oncology Targeted Therapy Market Forecast
10.2.3 Mexico Oncology Targeted Therapy Market Forecast
10.2.4 Brazil Oncology Targeted Therapy Market Forecast
10.3 APAC Oncology Targeted Therapy Forecast by Region (2024-2029)
10.3.1 China Oncology Targeted Therapy Market Forecast
10.3.2 Japan Oncology Targeted Therapy Market Forecast
10.3.3 Korea Oncology Targeted Therapy Market Forecast
10.3.4 Southeast Asia Oncology Targeted Therapy Market Forecast
10.3.5 India Oncology Targeted Therapy Market Forecast
10.3.6 Australia Oncology Targeted Therapy Market Forecast
10.4 Europe Oncology Targeted Therapy Forecast by Country (2024-2029)
10.4.1 Germany Oncology Targeted Therapy Market Forecast
10.4.2 France Oncology Targeted Therapy Market Forecast
10.4.3 UK Oncology Targeted Therapy Market Forecast
10.4.4 Italy Oncology Targeted Therapy Market Forecast
10.4.5 Russia Oncology Targeted Therapy Market Forecast
10.5 Middle East & Africa Oncology Targeted Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Oncology Targeted Therapy Market Forecast
10.5.2 South Africa Oncology Targeted Therapy Market Forecast
10.5.3 Israel Oncology Targeted Therapy Market Forecast
10.5.4 Turkey Oncology Targeted Therapy Market Forecast
10.5.5 GCC Countries Oncology Targeted Therapy Market Forecast
10.6 Global Oncology Targeted Therapy Forecast by Type (2024-2029)
10.7 Global Oncology Targeted Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Oncology Targeted Therapy Product Offered
11.1.3 Bayer Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Bayer Main Business Overview
11.1.5 Bayer Latest Developments
11.2 Eisai
11.2.1 Eisai Company Information
11.2.2 Eisai Oncology Targeted Therapy Product Offered
11.2.3 Eisai Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Eisai Main Business Overview
11.2.5 Eisai Latest Developments
11.3 Zelgen
11.3.1 Zelgen Company Information
11.3.2 Zelgen Oncology Targeted Therapy Product Offered
11.3.3 Zelgen Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Zelgen Main Business Overview
11.3.5 Zelgen Latest Developments
11.4 Cipla
11.4.1 Cipla Company Information
11.4.2 Cipla Oncology Targeted Therapy Product Offered
11.4.3 Cipla Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Cipla Main Business Overview
11.4.5 Cipla Latest Developments
11.5 Natco Pharma
11.5.1 Natco Pharma Company Information
11.5.2 Natco Pharma Oncology Targeted Therapy Product Offered
11.5.3 Natco Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Natco Pharma Main Business Overview
11.5.5 Natco Pharma Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Oncology Targeted Therapy Product Offered
11.6.3 AstraZeneca Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Oncology Targeted Therapy Product Offered
11.7.3 Novartis Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 Roche
11.8.1 Roche Company Information
11.8.2 Roche Oncology Targeted Therapy Product Offered
11.8.3 Roche Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Roche Main Business Overview
11.8.5 Roche Latest Developments
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Information
11.9.2 Bristol-Myers Squibb Oncology Targeted Therapy Product Offered
11.9.3 Bristol-Myers Squibb Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Bristol-Myers Squibb Main Business Overview
11.9.5 Bristol-Myers Squibb Latest Developments
11.10 Pfizer
11.10.1 Pfizer Company Information
11.10.2 Pfizer Oncology Targeted Therapy Product Offered
11.10.3 Pfizer Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Pfizer Main Business Overview
11.10.5 Pfizer Latest Developments
11.11 BEACON Pharma
11.11.1 BEACON Pharma Company Information
11.11.2 BEACON Pharma Oncology Targeted Therapy Product Offered
11.11.3 BEACON Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 BEACON Pharma Main Business Overview
11.11.5 BEACON Pharma Latest Developments
11.12 Jiangxi Shanxiang
11.12.1 Jiangxi Shanxiang Company Information
11.12.2 Jiangxi Shanxiang Oncology Targeted Therapy Product Offered
11.12.3 Jiangxi Shanxiang Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Jiangxi Shanxiang Main Business Overview
11.12.5 Jiangxi Shanxiang Latest Developments
11.13 Yao Pharma
11.13.1 Yao Pharma Company Information
11.13.2 Yao Pharma Oncology Targeted Therapy Product Offered
11.13.3 Yao Pharma Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Yao Pharma Main Business Overview
11.13.5 Yao Pharma Latest Developments
11.14 CSPC
11.14.1 CSPC Company Information
11.14.2 CSPC Oncology Targeted Therapy Product Offered
11.14.3 CSPC Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 CSPC Main Business Overview
11.14.5 CSPC Latest Developments
11.15 CHIATAI Tianqing
11.15.1 CHIATAI Tianqing Company Information
11.15.2 CHIATAI Tianqing Oncology Targeted Therapy Product Offered
11.15.3 CHIATAI Tianqing Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 CHIATAI Tianqing Main Business Overview
11.15.5 CHIATAI Tianqing Latest Developments
11.16 Simcere
11.16.1 Simcere Company Information
11.16.2 Simcere Oncology Targeted Therapy Product Offered
11.16.3 Simcere Oncology Targeted Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Simcere Main Business Overview
11.16.5 Simcere Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Oncology Targeted Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Sorafenib
Table 3. Major Players of Lenvatinib
Table 4. Major Players of Regorafenib
Table 5. Major Players of Osimertinib
Table 6. Major Players of Anlotinib
Table 7. Major Players of Alectinib
Table 8. Major Players of Other
Table 9. Oncology Targeted Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Oncology Targeted Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 11. Global Oncology Targeted Therapy Market Size Market Share by Type (2018-2023)
Table 12. Oncology Targeted Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 13. Global Oncology Targeted Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 14. Global Oncology Targeted Therapy Market Size Market Share by Application (2018-2023)
Table 15. Global Oncology Targeted Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 16. Global Oncology Targeted Therapy Revenue Market Share by Player (2018-2023)
Table 17. Oncology Targeted Therapy Key Players Head office and Products Offered
Table 18. Oncology Targeted Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Oncology Targeted Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 22. Global Oncology Targeted Therapy Market Size Market Share by Regions (2018-2023)
Table 23. Global Oncology Targeted Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 24. Global Oncology Targeted Therapy Revenue Market Share by Country/Region (2018-2023)
Table 25. Americas Oncology Targeted Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 26. Americas Oncology Targeted Therapy Market Size Market Share by Country (2018-2023)
Table 27. Americas Oncology Targeted Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 28. Americas Oncology Targeted Therapy Market Size Market Share by Type (2018-2023)
Table 29. Americas Oncology Targeted Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 30. Americas Oncology Targeted Therapy Market Size Market Share by Application (2018-2023)
Table 31. APAC Oncology Targeted Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 32. APAC Oncology Targeted Therapy Market Size Market Share by Region (2018-2023)
Table 33. APAC Oncology Targeted Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 34. APAC Oncology Targeted Therapy Market Size Market Share by Type (2018-2023)
Table 35. APAC Oncology Targeted Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 36. APAC Oncology Targeted Therapy Market Size Market Share by Application (2018-2023)
Table 37. Europe Oncology Targeted Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 38. Europe Oncology Targeted Therapy Market Size Market Share by Country (2018-2023)
Table 39. Europe Oncology Targeted Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 40. Europe Oncology Targeted Therapy Market Size Market Share by Type (2018-2023)
Table 41. Europe Oncology Targeted Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 42. Europe Oncology Targeted Therapy Market Size Market Share by Application (2018-2023)
Table 43. Middle East & Africa Oncology Targeted Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Oncology Targeted Therapy Market Size Market Share by Region (2018-2023)
Table 45. Middle East & Africa Oncology Targeted Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Oncology Targeted Therapy Market Size Market Share by Type (2018-2023)
Table 47. Middle East & Africa Oncology Targeted Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 48. Middle East & Africa Oncology Targeted Therapy Market Size Market Share by Application (2018-2023)
Table 49. Key Market Drivers & Growth Opportunities of Oncology Targeted Therapy
Table 50. Key Market Challenges & Risks of Oncology Targeted Therapy
Table 51. Key Industry Trends of Oncology Targeted Therapy
Table 52. Global Oncology Targeted Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 53. Global Oncology Targeted Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 54. Global Oncology Targeted Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 55. Global Oncology Targeted Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 56. Bayer Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 57. Bayer Oncology Targeted Therapy Product Offered
Table 58. Bayer Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 59. Bayer Main Business
Table 60. Bayer Latest Developments
Table 61. Eisai Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 62. Eisai Oncology Targeted Therapy Product Offered
Table 63. Eisai Main Business
Table 64. Eisai Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Eisai Latest Developments
Table 66. Zelgen Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 67. Zelgen Oncology Targeted Therapy Product Offered
Table 68. Zelgen Main Business
Table 69. Zelgen Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Zelgen Latest Developments
Table 71. Cipla Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 72. Cipla Oncology Targeted Therapy Product Offered
Table 73. Cipla Main Business
Table 74. Cipla Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Cipla Latest Developments
Table 76. Natco Pharma Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 77. Natco Pharma Oncology Targeted Therapy Product Offered
Table 78. Natco Pharma Main Business
Table 79. Natco Pharma Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Natco Pharma Latest Developments
Table 81. AstraZeneca Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 82. AstraZeneca Oncology Targeted Therapy Product Offered
Table 83. AstraZeneca Main Business
Table 84. AstraZeneca Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. AstraZeneca Latest Developments
Table 86. Novartis Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 87. Novartis Oncology Targeted Therapy Product Offered
Table 88. Novartis Main Business
Table 89. Novartis Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Novartis Latest Developments
Table 91. Roche Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 92. Roche Oncology Targeted Therapy Product Offered
Table 93. Roche Main Business
Table 94. Roche Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Roche Latest Developments
Table 96. Bristol-Myers Squibb Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 97. Bristol-Myers Squibb Oncology Targeted Therapy Product Offered
Table 98. Bristol-Myers Squibb Main Business
Table 99. Bristol-Myers Squibb Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Bristol-Myers Squibb Latest Developments
Table 101. Pfizer Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 102. Pfizer Oncology Targeted Therapy Product Offered
Table 103. Pfizer Main Business
Table 104. Pfizer Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Pfizer Latest Developments
Table 106. BEACON Pharma Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 107. BEACON Pharma Oncology Targeted Therapy Product Offered
Table 108. BEACON Pharma Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 109. BEACON Pharma Main Business
Table 110. BEACON Pharma Latest Developments
Table 111. Jiangxi Shanxiang Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 112. Jiangxi Shanxiang Oncology Targeted Therapy Product Offered
Table 113. Jiangxi Shanxiang Main Business
Table 114. Jiangxi Shanxiang Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Jiangxi Shanxiang Latest Developments
Table 116. Yao Pharma Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 117. Yao Pharma Oncology Targeted Therapy Product Offered
Table 118. Yao Pharma Main Business
Table 119. Yao Pharma Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Yao Pharma Latest Developments
Table 121. CSPC Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 122. CSPC Oncology Targeted Therapy Product Offered
Table 123. CSPC Main Business
Table 124. CSPC Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. CSPC Latest Developments
Table 126. CHIATAI Tianqing Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 127. CHIATAI Tianqing Oncology Targeted Therapy Product Offered
Table 128. CHIATAI Tianqing Main Business
Table 129. CHIATAI Tianqing Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. CHIATAI Tianqing Latest Developments
Table 131. Simcere Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 132. Simcere Oncology Targeted Therapy Product Offered
Table 133. Simcere Main Business
Table 134. Simcere Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Simcere Latest Developments
Table 1. Oncology Targeted Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Sorafenib
Table 3. Major Players of Lenvatinib
Table 4. Major Players of Regorafenib
Table 5. Major Players of Osimertinib
Table 6. Major Players of Anlotinib
Table 7. Major Players of Alectinib
Table 8. Major Players of Other
Table 9. Oncology Targeted Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global Oncology Targeted Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 11. Global Oncology Targeted Therapy Market Size Market Share by Type (2018-2023)
Table 12. Oncology Targeted Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 13. Global Oncology Targeted Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 14. Global Oncology Targeted Therapy Market Size Market Share by Application (2018-2023)
Table 15. Global Oncology Targeted Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 16. Global Oncology Targeted Therapy Revenue Market Share by Player (2018-2023)
Table 17. Oncology Targeted Therapy Key Players Head office and Products Offered
Table 18. Oncology Targeted Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Oncology Targeted Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 22. Global Oncology Targeted Therapy Market Size Market Share by Regions (2018-2023)
Table 23. Global Oncology Targeted Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 24. Global Oncology Targeted Therapy Revenue Market Share by Country/Region (2018-2023)
Table 25. Americas Oncology Targeted Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 26. Americas Oncology Targeted Therapy Market Size Market Share by Country (2018-2023)
Table 27. Americas Oncology Targeted Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 28. Americas Oncology Targeted Therapy Market Size Market Share by Type (2018-2023)
Table 29. Americas Oncology Targeted Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 30. Americas Oncology Targeted Therapy Market Size Market Share by Application (2018-2023)
Table 31. APAC Oncology Targeted Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 32. APAC Oncology Targeted Therapy Market Size Market Share by Region (2018-2023)
Table 33. APAC Oncology Targeted Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 34. APAC Oncology Targeted Therapy Market Size Market Share by Type (2018-2023)
Table 35. APAC Oncology Targeted Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 36. APAC Oncology Targeted Therapy Market Size Market Share by Application (2018-2023)
Table 37. Europe Oncology Targeted Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 38. Europe Oncology Targeted Therapy Market Size Market Share by Country (2018-2023)
Table 39. Europe Oncology Targeted Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 40. Europe Oncology Targeted Therapy Market Size Market Share by Type (2018-2023)
Table 41. Europe Oncology Targeted Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 42. Europe Oncology Targeted Therapy Market Size Market Share by Application (2018-2023)
Table 43. Middle East & Africa Oncology Targeted Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Oncology Targeted Therapy Market Size Market Share by Region (2018-2023)
Table 45. Middle East & Africa Oncology Targeted Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Oncology Targeted Therapy Market Size Market Share by Type (2018-2023)
Table 47. Middle East & Africa Oncology Targeted Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 48. Middle East & Africa Oncology Targeted Therapy Market Size Market Share by Application (2018-2023)
Table 49. Key Market Drivers & Growth Opportunities of Oncology Targeted Therapy
Table 50. Key Market Challenges & Risks of Oncology Targeted Therapy
Table 51. Key Industry Trends of Oncology Targeted Therapy
Table 52. Global Oncology Targeted Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 53. Global Oncology Targeted Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 54. Global Oncology Targeted Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 55. Global Oncology Targeted Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 56. Bayer Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 57. Bayer Oncology Targeted Therapy Product Offered
Table 58. Bayer Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 59. Bayer Main Business
Table 60. Bayer Latest Developments
Table 61. Eisai Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 62. Eisai Oncology Targeted Therapy Product Offered
Table 63. Eisai Main Business
Table 64. Eisai Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Eisai Latest Developments
Table 66. Zelgen Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 67. Zelgen Oncology Targeted Therapy Product Offered
Table 68. Zelgen Main Business
Table 69. Zelgen Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Zelgen Latest Developments
Table 71. Cipla Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 72. Cipla Oncology Targeted Therapy Product Offered
Table 73. Cipla Main Business
Table 74. Cipla Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Cipla Latest Developments
Table 76. Natco Pharma Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 77. Natco Pharma Oncology Targeted Therapy Product Offered
Table 78. Natco Pharma Main Business
Table 79. Natco Pharma Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Natco Pharma Latest Developments
Table 81. AstraZeneca Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 82. AstraZeneca Oncology Targeted Therapy Product Offered
Table 83. AstraZeneca Main Business
Table 84. AstraZeneca Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. AstraZeneca Latest Developments
Table 86. Novartis Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 87. Novartis Oncology Targeted Therapy Product Offered
Table 88. Novartis Main Business
Table 89. Novartis Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Novartis Latest Developments
Table 91. Roche Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 92. Roche Oncology Targeted Therapy Product Offered
Table 93. Roche Main Business
Table 94. Roche Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Roche Latest Developments
Table 96. Bristol-Myers Squibb Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 97. Bristol-Myers Squibb Oncology Targeted Therapy Product Offered
Table 98. Bristol-Myers Squibb Main Business
Table 99. Bristol-Myers Squibb Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Bristol-Myers Squibb Latest Developments
Table 101. Pfizer Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 102. Pfizer Oncology Targeted Therapy Product Offered
Table 103. Pfizer Main Business
Table 104. Pfizer Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. Pfizer Latest Developments
Table 106. BEACON Pharma Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 107. BEACON Pharma Oncology Targeted Therapy Product Offered
Table 108. BEACON Pharma Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 109. BEACON Pharma Main Business
Table 110. BEACON Pharma Latest Developments
Table 111. Jiangxi Shanxiang Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 112. Jiangxi Shanxiang Oncology Targeted Therapy Product Offered
Table 113. Jiangxi Shanxiang Main Business
Table 114. Jiangxi Shanxiang Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Jiangxi Shanxiang Latest Developments
Table 116. Yao Pharma Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 117. Yao Pharma Oncology Targeted Therapy Product Offered
Table 118. Yao Pharma Main Business
Table 119. Yao Pharma Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Yao Pharma Latest Developments
Table 121. CSPC Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 122. CSPC Oncology Targeted Therapy Product Offered
Table 123. CSPC Main Business
Table 124. CSPC Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. CSPC Latest Developments
Table 126. CHIATAI Tianqing Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 127. CHIATAI Tianqing Oncology Targeted Therapy Product Offered
Table 128. CHIATAI Tianqing Main Business
Table 129. CHIATAI Tianqing Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. CHIATAI Tianqing Latest Developments
Table 131. Simcere Details, Company Type, Oncology Targeted Therapy Area Served and Its Competitors
Table 132. Simcere Oncology Targeted Therapy Product Offered
Table 133. Simcere Main Business
Table 134. Simcere Oncology Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Simcere Latest Developments
LIST OF FIGURES
Figure 1. Oncology Targeted Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Targeted Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Oncology Targeted Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Oncology Targeted Therapy Sales Market Share by Country/Region (2022)
Figure 8. Oncology Targeted Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Oncology Targeted Therapy Market Size Market Share by Type in 2022
Figure 10. Oncology Targeted Therapy in Hospital
Figure 11. Global Oncology Targeted Therapy Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Oncology Targeted Therapy in Retail Pharmacy
Figure 13. Global Oncology Targeted Therapy Market: Retail Pharmacy (2018-2023) & ($ Millions)
Figure 14. Oncology Targeted Therapy in Other
Figure 15. Global Oncology Targeted Therapy Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Oncology Targeted Therapy Market Size Market Share by Application in 2022
Figure 17. Global Oncology Targeted Therapy Revenue Market Share by Player in 2022
Figure 18. Global Oncology Targeted Therapy Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Oncology Targeted Therapy Market Size 2018-2023 ($ Millions)
Figure 20. APAC Oncology Targeted Therapy Market Size 2018-2023 ($ Millions)
Figure 21. Europe Oncology Targeted Therapy Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Oncology Targeted Therapy Market Size 2018-2023 ($ Millions)
Figure 23. Americas Oncology Targeted Therapy Value Market Share by Country in 2022
Figure 24. United States Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Oncology Targeted Therapy Market Size Market Share by Region in 2022
Figure 29. APAC Oncology Targeted Therapy Market Size Market Share by Type in 2022
Figure 30. APAC Oncology Targeted Therapy Market Size Market Share by Application in 2022
Figure 31. China Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Oncology Targeted Therapy Market Size Market Share by Country in 2022
Figure 38. Europe Oncology Targeted Therapy Market Size Market Share by Type (2018-2023)
Figure 39. Europe Oncology Targeted Therapy Market Size Market Share by Application (2018-2023)
Figure 40. Germany Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Oncology Targeted Therapy Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Oncology Targeted Therapy Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Oncology Targeted Therapy Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 54. APAC Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 55. Europe Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 57. United States Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Canada Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 61. China Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Japan Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 63. Korea Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 65. India Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Australia Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 67. Germany Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 68. France Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 69. UK Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Italy Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Russia Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Spain Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Israel Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Global Oncology Targeted Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Oncology Targeted Therapy Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Oncology Targeted Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Targeted Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Oncology Targeted Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Oncology Targeted Therapy Sales Market Share by Country/Region (2022)
Figure 8. Oncology Targeted Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Oncology Targeted Therapy Market Size Market Share by Type in 2022
Figure 10. Oncology Targeted Therapy in Hospital
Figure 11. Global Oncology Targeted Therapy Market: Hospital (2018-2023) & ($ Millions)
Figure 12. Oncology Targeted Therapy in Retail Pharmacy
Figure 13. Global Oncology Targeted Therapy Market: Retail Pharmacy (2018-2023) & ($ Millions)
Figure 14. Oncology Targeted Therapy in Other
Figure 15. Global Oncology Targeted Therapy Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Oncology Targeted Therapy Market Size Market Share by Application in 2022
Figure 17. Global Oncology Targeted Therapy Revenue Market Share by Player in 2022
Figure 18. Global Oncology Targeted Therapy Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Oncology Targeted Therapy Market Size 2018-2023 ($ Millions)
Figure 20. APAC Oncology Targeted Therapy Market Size 2018-2023 ($ Millions)
Figure 21. Europe Oncology Targeted Therapy Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Oncology Targeted Therapy Market Size 2018-2023 ($ Millions)
Figure 23. Americas Oncology Targeted Therapy Value Market Share by Country in 2022
Figure 24. United States Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Oncology Targeted Therapy Market Size Market Share by Region in 2022
Figure 29. APAC Oncology Targeted Therapy Market Size Market Share by Type in 2022
Figure 30. APAC Oncology Targeted Therapy Market Size Market Share by Application in 2022
Figure 31. China Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Oncology Targeted Therapy Market Size Market Share by Country in 2022
Figure 38. Europe Oncology Targeted Therapy Market Size Market Share by Type (2018-2023)
Figure 39. Europe Oncology Targeted Therapy Market Size Market Share by Application (2018-2023)
Figure 40. Germany Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Oncology Targeted Therapy Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Oncology Targeted Therapy Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Oncology Targeted Therapy Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Oncology Targeted Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 54. APAC Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 55. Europe Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 57. United States Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 58. Canada Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 61. China Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Japan Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 63. Korea Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 65. India Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Australia Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 67. Germany Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 68. France Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 69. UK Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Italy Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Russia Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 72. Spain Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Israel Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Oncology Targeted Therapy Market Size 2024-2029 ($ Millions)
Figure 78. Global Oncology Targeted Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Oncology Targeted Therapy Market Size Market Share Forecast by Application (2024-2029)
